Crucell at a Glance
Who we are
Crucell is a fully integrated biopharmaceutical company. We focus on developing, producing and marketing products that combat infectious diseases. We are the largest independent vaccine company in the world. The sustainability of our business is demonstrated by our solid balance sheet and strong cash position, as a consequence we do not need to raise capital in the foreseeable future. For a company of our size, we invest relatively heavily in research and development: our R&D expenditures in 2008 were €70 million.
Strategy
We develop products that address currently unmet medical needs, particularly in the field of infectious diseases. We have a fully integrated infrastructure for in-house development, production and marketing of vaccines, and we are leveraging our knowledge in the vaccines field to excel in the antibodies market. Our competitive edge comes from our proprietary technology platforms like PER.C6®, which is used to produce high-value biotech products in scalable and cost-efficient ways. This combination of markets we operate in, technological knowledge and quality marketed products, positions us to be a major player in the multi-billion dollar biopharmaceutical arena.
€171.0 mln - Cash and cash equivalents at year-end 2008. Strong cash position to invest in profitable growth. 33% - Growth in 2008. Revenues and other operating income growth. We have strategic partnerships with leading international healthcare companies. €0.22 - Net profit per share in 2008. Compared to net loss per share of €0.66 in 2007.
Partners and licensees
In addition to our own research and development activities, we have strategic partnerships with several leading healthcare companies. Through these agreements, our technologies play a vital role in the development of a vast number of vaccines and antibody products. Some examples of partners and licensees we work with are mentioned below.
- CSL
- DSM Biologics
- Gedeon Richter
- GSK
- MedImmune
- Merck
- Novartis
- Sanofi pasteur
- Talecris
- Wyeth
Why infectious diseases?
Infectious diseases currently account for a significant number of human casualties throughout the world. The number of infectious outbreaks is increasing for many reasons: higher population density which raises exposure to infectious agents; an ageing population which is more susceptible to infection; and the volume of global travel which boosts the potential for spreading diseases across borders.